ARDIZZONI, ANDREA
ARDIZZONI, ANDREA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
2025 Angelicola, Stefania; Giunchi, Francesca; Ruzzi, Francesca; Frascino, Mariateresa; Pitzalis, Mary; Scalambra, Laura; Semprini, Maria Sofia; Pittino, Olga Maria; Cappello, Chiara; Siracusa, Irene; Chillico, Ilaria Candida; Di Noia, Martina; Turato, Cristian; De Siervi, Silvia; Lescai, Francesco; Ciavattini, Teresa; Lopatriello, Giulia; Bertoli, Luca; De Jonge, Hugo; Iamele, Luisa; Altimari, Annalisa; Gruppioni, Elisa; Ardizzoni, Andrea; Rossato, Marzia; Gelsomino, Francesco; Lollini, Pier-Luigi; Palladini, Arianna
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial
2024 Garon, Edward B.; Lu, Shun; Goto, Yasushi; De Marchi, Pedro; Paz-Ares, Luis; Spigel, David R.; Thomas, Michael; Yang, James Chih-Hsin; Ardizzoni, Andrea; Barlesi, Fabrice; Orlov, Sergey; Yoshioka, Hiroshige; Mountzios, Giannis; Khanna, Sadhvi; Bossen, Claudia; Carbini, Mariana; Turri, Sabine; Myers, Andrea; Cho, Byoung Chul
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations
2024 Di Federico, Alessandro; Angelicola, Stefania; Frascino, Mariateresa; Siracusa, Irene; Bisanti, Beatrice; Ruzzi, Francesca; Semprini, Maria Sofia; De Jonge, Hugo; De Giglio, Andrea; Sperandi, Francesca; Brocchi, Stefano; Melotti, Barbara; Giunchi, Francesca; Gruppioni, Elisa; Altimari, Annalisa; Lollini, Pier-Luigi; Ardizzoni, Andrea; Palladini, Arianna; Gelsomino, Francesco
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy
2024 De Giglio, Andrea; Leonetti, Alessandro; Comito, Francesca; Filippini, Daria Maria; Mollica, Veronica; Rihawi, Karim; Peroni, Marianna; Mazzaschi, Giulia; Ricciotti, Ilaria; Carosi, Francesca; Marchetti, Andrea; Rosellini, Matteo; Gagliano, Ambrogio; Favorito, Valentina; Nobili, Elisabetta; Gelsomino, Francesco; Melotti, Barbara; Marchese, Paola Valeria; Sperandi, Francesca; Di Federico, Alessandro; Buti, Sebastiano; Perrone, Fabiana; Massari, Francesco; Pantaleo, Maria Abbondanza; Tiseo, Marcello; Ardizzoni, Andrea
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report
2024 De Giglio, Andrea; Zacchini, Federico; Venturi, Giulia; Di Federico, Alessandro; Parisi, Claudia; Dall'Olio, Filippo Gustavo; Ricciotti, Ilaria; Favorito, Valentina; Gagliano, Ambrogio; De Biase, Dario; Maloberti, Thais; Altimari, Annalisa; Gruppioni, Elisa; Tallini, Giovanni; Melotti, Barbara; Sperandi, Francesca; Gelsomino, Francesco; Montanaro, Lorenzo; Ardizzoni, Andrea
Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib
2024 Di Federico A.; De Giglio A.; Sperandi F.; Melotti B.; Ardizzoni A.; Gelsomino F.
Histopathological Evidence for a Non-Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case Report
2024 Rossi S.; Costa R.; di Federico A.; Lo Bianco F.; D'Angelo R.; Asioli G.M.; De Giglio A.; Sperandi F.; Guarino M.; Rinaldi R.; Ardizzoni A.; Cenacchi G.; Gelsomino F.
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary
2024 Cavazzoni A.; Salamon I.; Fumarola C.; Gallerani G.; Laprovitera N.; Gelsomino F.; Riefolo M.; Rihawi K.; Porcellini E.; Rossi T.; Mazzeschi M.; Naddeo M.; Serravalle S.; Broseghini E.; Agostinis F.; Deas O.; Roncarati R.; Durante G.; Pace I.; Lauriola M.; Garajova I.; Calin G.A.; Bonafe M.; D'Errico A.; Petronini P.G.; Cairo S.; Ardizzoni A.; Sales G.; Ferracin M.
Transdermal Fentanyl in Patients with Cachexia-A Scoping Review
2024 Carlini, Andrea; Scarpi, Emanuela; Bettini, Carla; Ardizzoni, Andrea; Donati, Costanza Maria; Fabbri, Laura; Ghetti, Francesca; Martini, Francesca; Ricci, Marianna; Sansoni, Elisabetta; Tenti, Maria Valentina; Morganti, Alessio Giuseppe; Bruera, Eduardo; Maltoni, Marco Cesare; Rossi, Romina
Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial
2023 Guido, Alessandra; Cuicchi, Dajana; Castellucci, Paolo; Cellini, Francesco; Di Fabio, Francesca; Llimpe, Fabiola Lorena Rojas; Strigari, Lidia; Buwenge, Milly; Cilla, Savino; Deodato, Francesco; Macchia, Gabriella; Galietta, Erika; Golfieri, Rita; Ardizzoni, Andrea; Zagari, Rocco Maurizio; Fanti, Stefano; Poggioli, Gilberto; Fuccio, Lorenzo; Morganti, Alessio G
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors
2023 Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC
2023 Zhou, Caicun; Solomon, Benjamin; Loong, Herbert H.; Park, Keunchil; Pérol, Maurice; Arriola, Edurne; Novello, Silvia; Han, Baohui; Zhou, Jianying; Ardizzoni, Andrea; Mak, M. Perez; Santini, Fernando C.; Elamin, Yasir Y.; Drilon, Alexander; Wolf, Jürgen; Payakachat, Nalin; Uh, Minji K.; Rajakumar, Deborah; Han, Hongmei; Puri, Tarun; Soldatenkova, Victoria; Lin, A. Bence; Lin, Boris K.; Goto, Koichi
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
2023 Rossi, Simone; Cani, Ilaria; Raschi, Emanuel; Comito, Francesca; Rinaldi, Rita; Ardizzoni, Andrea; Guarino, Maria; Gelsomino, Francesco
Novel therapeutic strategies for recurrent SCLC
2023 Moliner, Laura; Zhang, Bingnan; Lamberti, Giuseppe; Ardizzoni, Andrea; Byers, Lauren A.; Califano, Raffaele
Peripheral nervous system adverse events associated with immune checkpoint inhibitors
2023 Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lamberti G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M.
Predictors of Survival to Immunotherapy and Chemoimmunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis
2023 Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale
2022 Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Follador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC
2022 Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System
2022 Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; Poluzzi E.; Pagotto U.; Di Dalmazi G.
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
2022 Noronha, Ashish; Belugali Nataraj, Nishanth; Lee, Joo Sang; Zhitomirsky, Benny; Oren, Yaara; Oster, Sara; Lindzen, Moshit; Mukherjee, Saptaparna; Will, Rainer; Ghosh, Soma; Simoni-Nieves, Arturo; Verma, Aakanksha; Chatterjee, Rishita; Borgoni, Simone; Robinson, Welles; Sinha, Sanju; Brandis, Alexander; Kerr, D Lucas; Wu, Wei; Sekar, Arunachalam; Giri, Suvendu; Chung, Youngmin; Drago-Garcia, Diana; Danysh, Brian P; Lauriola, Mattia; Fiorentino, Michelangelo; Ardizzoni, Andrea; Oren, Moshe; Blakely, Collin M; Ezike, Jideofor; Wiemann, Stefan; Parida, Laxmi; Bivona, Trever G; Aqeilan, Rami I; Brugge, Joan S; Regev, Aviv; Getz, Gad; Ruppin, Eytan; Yarden, Yosef